Assembly Biosciences (ASMB) Return on Capital Employed (2011 - 2026)

Assembly Biosciences' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 1.28% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 7017.0% year-over-year to 1.28%; the TTM figure through Mar 2026 stood at 1.28% (up 7017.0% YoY), while the FY2025 annual figure was 0.92%, up 5572.0% from the prior year.
• Return on Capital Employed was 1.28% for Q1 2026 at Assembly Biosciences, down from 0.64% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 0.64% in Q4 2025 to a low of 144.45% in Q3 2023.
• Historically, Return on Capital Employed has averaged 80.63% across 5 years, with a median of 77.38% in 2022.
• The sharpest annual moves came in 2022 and 2024: Return on Capital Employed sank 6905 bps in 2022, then jumped 7426 bps in 2024.
• A 5-year view of Return on Capital Employed shows it stood at 98.69% in 2022, then decreased by 19 bps to 117.54% in 2023, then jumped by 38 bps to 73.36% in 2024, then surged by 99 bps to 0.64% in 2025, then sank by 100 bps to 1.28% in 2026.
• The last three Return on Capital Employed figures came in at 1.28% (Q1 2026), 0.64% (Q4 2025), and 40.6% (Q3 2025), per Business Quant data.